Prevalence of and risk factors for depressive symptoms among people living with HIV/AIDS receiving antiretroviral treatment in Nigeria
Zulkiflu Musa Argungu, Ado Shehu, Deborah JY and Jama MD
Background: Depression is a common mental disorder (CMD) with significant contributions to the burden of disease. It can lead to high social, economic and individual costs because it accounts for one-third of the days missed at work and a fifth of all primary health-care appointment.
Objective: We aimed to explore the prevalence of and risk factors for depressive symptoms among people living with HIV/AIDS (PLWHA) receiving antiretroviral treatment (ART) in Kebbi State, Nigeria.
Method: A cross-sectional study evaluating adult PLWHA receiving ART in three designated clinical hospitals was conducted. The validated Beck Depression Inventory (BDI) was used to assess depressive symptoms, ineligible participants.
Result: Multinomial regression analysis was used to explore the risk factors for depressive symptoms. 348 participants were finally included in all analyses. 40.3% were found to have depressive symptoms with 13.7% having mild depressive symptoms and 26.6% having moderate to severe depressive symptoms.
Conclusion: The results of multinomial regression analysis suggested that being married or living with a partner, recent experience of ART-related side effects, and/or history of HCV infection were positively associated with mild depressive symptoms, while increasing age was positively associated with moderate to severe depressive symptoms.
Zulkiflu Musa Argungu, Ado Shehu, Deborah JY, Jama MD. Prevalence of and risk factors for depressive symptoms among people living with HIV/AIDS receiving antiretroviral treatment in Nigeria. Int J Adv Psychiatric Nurs 2020;2(2):21-25.